In this study, Rorive et al. compared the expression level of galectin-1 in high-grade astrocytic tumors from 41 patients (26 with GBM) who survived < 12 months and > 24 months; the expression level of galectin-1 was significantly correlated with survival [13], but no details of treatment modality were reported. Here, LGALS1 is linked to glioblastoma.